Sort By:
Featured

Smallpox Vaccine

This research study will evaluate the safety and effectiveness of a vaccine to protect against Smallpox. This study will last approximately up to 39 weeks with 6 number of visits to our office and 1 telephone call. While the World Health Organization officially declared successful global eradication in 1980, the threat of a small pox outbreak still exists through bioterrorism and risk of natural re-emergence of the virus.

View Trial Details
Ages 18 - 45
Compensation* $475
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Pneumococcal Vaccine

This study is to evalute the safety and effectiveness of a study vaccine that may provide broader coverage against the leading serotypes associated with pneumococcal disease. The study will last approximately 6 months with two visits to our office and two telephone calls.

View Trial Details
Ages 65+
Compensation* $110
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

E. Coli Vaccine

RCR is currently enrolling healthy 60-85 year olds to evaluate a vaccine that could potentially prevent E. Coli that can cause sepsis.

View Trial Details
Ages 60 - 85
Study Topics Vaccine

Pediatrics Meningitis Vaccine

Two month old patients of Legacy Pediatrics may have an opportunity to participate in this study.

View Trial Details
Ages 0 - 1
Study Topics Pediatric, Vaccine

C. Diff. Vaccine

Investigational vaccine to prevent Clostridium Difficile

View Trial Details
Ages 60+
Compensation* $250
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.